InvestorsHub Logo
Followers 67
Posts 826
Boards Moderated 0
Alias Born 03/19/2009

Re: zenvesting post# 9992

Thursday, 02/05/2015 5:44:04 AM

Thursday, February 05, 2015 5:44:04 AM

Post# of 10804
zenvesting...regarding FZMD.....

FZMD, co-founder and 30%+ owner resigned from the BOD today, but participated in a financing on 1/12/2015 @ $0.50.....not sure what to make of the mixed signals.

I have accumulated a small position on the bid over the past month, but Jonathon Brown's resignation today gives me pause.

Also, my calls to the company over the past month have gone un-returned, so it's hard to put too much trust in this company yet.......but I really like their business plan and the products they're selling, which seam to originate from MDXG. Here's a few questions I am trying to ask management about:



It appears (based on the 10-K) that Jonathon Brown no longer has any direct operational involvement with the company since August 2014. Brown's LinkedIn profile describes him as an "entrepreneur", so maybe after getting FZMD established he is moving on to another venture. Perhaps his departure from the BOD is for purposes of bringing in an independent director or someone more actively involved.

https://www.linkedin.com/profile/view?id=4592635&authType=name&authToken=YxMs&trk=prof-sb-browse_map-name

Part of what interests me about FZMD is my hunch that the company will make acquisitions or joint ventures a part of its growth strategy going forward, and not rely just on organic growth. For some of the privately-held, medical-related companies that FZMD is (or will be) doing business with, FZMD might offer a relatively attractive avenue to go public.

Although that first merger with a pharmacy-related company was not completed at the time of the reverse merger, I still think that FZMD is very much interested in getting some exposure in that area. If I recall correctly, FZMD CEO Alan Meeker already has a personal direct/indirect ownership position in a compound pharmacy via his investment in World Health Industries (an investor in FZMD).

Back in 2013, Rusty Shelton made a presentation at the Physician Hospitals of America 13th Annual Conference. Included in that presentation was an organizational chart (page 20) which pretty much outlines the areas that Fuse Medical would like to get involved in. Retail/compound pharmacy, toxicology, durable/home medical equipment, DNA evaluation, etc......

http://c.ymcdn.com/sites/physicianhospitals.site-ym.com/resource/resmgr/Conferene_Speaker_Presentations/Patterson,_Shelton_-_What_Yo.pdf

Your company's 10K indicates that it's principal supplier is Texas AmBioMed, LLC which supplies AmnioFix Nerve Wrap and EpiFix for wound care, but these products seam to originate from MiMedx (MDXG). What is Texas AmBioMed, LLC's role (i.e.: is it a sales subsidiary of MiMedx, or a licensing subsidiary of Fuse, or truly an entirely different third party?)



Texas AmBioMed is a licensed distributor of Mimedx, according to the 2012 distribution agreement between AmBioMed and Fuse Medical. A copy of that agreement was filed in an 8-K on September 26, 2014 (page 6).....

19.1. Trademarks. AMBIOMED is a licensed distributor of Mimedx. During the term of this Agreement, Distributor shall have the right to indicate to the public that it is an authorized distributor of the Products and to advertise such Products under the applicable trademarks, marks, and trade names of AMBIOMED and Mimedx as set forth in Exhibit D (“Trademarks”) and in the promotion and distribution of the Products; provided, however, that upon ninety (90) days’ prior written notice to Distributor, AMBIOMED or Mimedx may substitute alternative marks for any or all of the AMBIOMED/Mimedx Trademarks. All representations of AMBIOMED/Mimedx Trademarks that Distributor intends to use shall first be submitted to AMBIOMED/Mimedx for approval (which shall not be unreasonably withheld) of design, color and other details or shall be exact copies of those AmBioMed\Mimedx used by AMBIOMED/Mimedx. In addition, Distributor shall fully comply with all reasonable guidelines, if any, communicated by AMBIOMED/Mimedx concerning the use of AMBIOMED or Mimedx’s Trademarks.



http://www.sec.gov/Archives/edgar/data/319016/000147793214005148/fzmd_ex101.htm
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.